Physician profile
Anna Martz
NPI 1902374879
$1,317.10
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.47 · 2022: $615 · 2023: $333 · 2024: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $308.63 | 2022-2024 | Zepbound, Mounjaro |
| Novo Nordisk INC | $173.17 | 2022-2023 | Wegovy |
| Medtronic, INC. | $151.02 | 2021-2023 | Minimed 780g, Minimed 770g |
| Astrazeneca Pharmaceuticals LP | $150.95 | 2022 | |
| Scynexis, INC. | $150.00 | 2022 | |
| Gilead Sciences, INC. | $111.00 | 2022-2023 | |
| Mylan Specialty L.P. | $105.56 | 2023 | Yupelri |
| Ultragenyx Pharmaceutical INC. | $82.18 | 2023 | Crysvita |
| Abbvie INC. | $37.17 | 2023-2024 | |
| Alkermes, INC. | $29.04 | 2024 | Vivitrol |
| Hologic Sales and Service, LLC | $13.30 | 2022 | |
| Genentech USA, INC. | $5.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Martz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.